Evidence map›Paper›PMID 37563624›Full record

ArticleSystematic reviews2023

Melasma in people with darker skin types: a scoping review protocol on prevalence, treatment options for melasma and impact on quality of life.

Nomakhosi Mpofana, Buyisile Chibi, Nceba Gqaleni, Ahmed Hussein, Avenal Jane Finlayson, Kabelo Kgarosi, Ncoza Cordelia Dlova

Open access · goldAbstract read
In one paragraph

Article in Systematic reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Nomakhosi MpofanaDermatology Department, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, 4000, South Africa. mpofanancput@gmail.com.ORCID http://orcid.org/0000-0002-3007-1147
Buyisile ChibiCenter of Rural Health, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, 4000, South Africa.
Nceba GqaleniDiscipline of Traditional Medicine, University of KwaZulu-Natal, Durban, 4000, South Africa.
Ahmed HusseinDepartment of Chemistry, Cape Peninsula University of Technology, Bellville, 7535, South Africa.
Avenal Jane FinlaysonDurban University of Technology, Durban, 4000, South Africa.
Kabelo KgarosiUniversity of Pretoria, Pretoria, 0002, South Africa.
Ncoza Cordelia DlovaDermatology Department, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, 4000, South Africa.
Durban University of Technology · ZAUniversity of KwaZulu-Natal · ZACape Peninsula University of Technology · ZAUniversity of Pretoria · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMelasma is one of the most encountered dermatoses in dermatology and skin care clinics. It is a challenging chronic, recurrent condition associated with hyperpigmentation. Its aetiology is poorly understood. Melasma affects all races and gender but is more prevalent in women with darker skin types. Being a facial lesion, melasma has a severe impact on quality of life due to its disfigurement. While many modalities of treatment for melasma exists, unfortunately, effectiveness and safety remain a huge concern. Treatment modalities are variable and often unsatisfactory. The objective of this scoping review is to systemically map available evidence from literature regarding melasma on people with darker skin types, garner insight as to how melasma affects the quality of life and begin to investigate and gain understanding on effectiveness of different treatments used for melasma.

methodsA scoping review guided by Arksey and O'Malley's framework, the enhancements and recommendations of Levac, Colquhoun and O'Brien, Daudt and associates and the 2015 Johanna Briggs Institute's guidelines will be conducted. Systematic electronic searches of databases and search engines will include Scopus, PubMed, CINAHL Complete, Cochrane, Science Direct, and Web of Science which will be conducted to attain published peer-reviewed articles of all study designs excluding reviews and grey literature. All literature that meets the inclusion criteria, research question and sub-question will be included in this review. All the retrieved literature will be exported to an Endnote X20 library. Quality appraisal of the included articles will be conducted using the mixed methods appraisal tool (MMAT) 2018 version. DISCUSSION: We anticipate mapping relevant literature on the melasma, investigating the effectiveness of treatment options of melasma as well as evaluating its association with quality of life in people with darker skin types. This study is likely to reveal research gaps, which could guide future implementation research on melasma treatment interventions. SYSTEMATIC REVIEW REGISTRATION: This protocol has been registered a priori with OSF and is accessible on this link: https://osf.io/ru3jc/ .

Indexed as

MelanosisQuality of LifeFemaleHumansPrevalenceResearch DesignScoping Reviews as TopicChloasmaHypermelanosisHyperpigmentationMelasmaTherapyTreatment

Identifiers

PMID37563624
PMCPMC10416367
OpenAlexW4385741584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.